SCHEMBL5889387

SCHEMBL5889387

CCC(CC)OC(=O)C=CC#N

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CTSK P43235 2/20 0.33
HCAR2 Q8TDS4 2/20 0.33
CTSL P07711 1/20 0.31
CTSB P07858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1924505 0.88 RNPEP (0.33) CTSKHCAR2
SCHEMBL819756 0.85 PRKCA (0.38) CTSKHCAR2CTSLCTSB
SCHEMBL2537821 0.83 HCAR2 (0.44) CTSKHCAR2
SCHEMBL15355448 0.83 HCAR2 (0.44) CTSKHCAR2
SCHEMBL5175845 0.83 HCAR2 (0.44) CTSKHCAR2
SCHEMBL1333356 0.82 HCAR2 (0.35) HCAR2
SCHEMBL16800710 0.79 CTSK (0.37) CTSKHCAR2
SCHEMBL230497 0.77 HCAR2 (0.56) HCAR2
SCHEMBL9068914 0.77 CTSK (0.36) CTSKHCAR2
SCHEMBL15855999 0.77 CTSK (0.36) CTSKHCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260112694-A1 SYSTEM AND METHOD FOR IMPROVED BATTERY STRUCTURAL PROPERTIES Anthro Energy, Inc. (US) 2026-04-23 US disclosed
US-20250372706-A1 SYSTEM AND METHOD FOR IMPROVED BATTERY STRUCTURAL PROPERTIES Anthro Energy, Inc. (US) 2025-12-04 US disclosed
US-12482860-B2 System and method for improved battery structural properties Anthro Energy, Inc. (US) 2025-11-25 US disclosed
US-20250273736-A1 FLEXIBLE BATTERY Anthro Energy, Inc. (US) 2025-08-28 US disclosed
US-12357581-B2 Nanoparticles comprising copolymeric or homopolymeric compounds which comprise cyanoacrylate subunits SINTEFF TTO AS (NO) 2025-07-15 US disclosed
US-20250149631-A1 SYSTEM AND METHOD FOR IMPROVED BATTERY STRUCTURAL PROPERTIES Anthro Energy, Inc. (US) 2025-05-08 US disclosed
WO-2025091014-A1 SYSTEM AND METHOD FOR IMPROVED BATTERY STRUCTURAL PROPERTIES Anthro Energy, Inc. (US) 2025-05-01 WO disclosed
US-20220160645-A1 NANOPARTICLES COMPRISING COPOLYMERIC OR HOMOPOLYMERIC COMPOUNDS WHICH COMPRISE CYANOACRYLATE SUBUNITS SINTEF TTO AS (NO) 2022-05-26 US disclosed
EP-3952836-A1 NANOPARTICLES COMPRISING COPOLYMERIC OR HOMOPOLYMERIC COMPOUNDS WHICH COMPRISE CYANOACRYLATE SUBUNITS SINTEF TTO AS (NO) 2022-02-16 EP disclosed
CN-113950320-A Nanoparticles comprising copolymerized or homopolymerized compounds containing cyanoacrylate subunits 新泰福托特股份有限公司 2022-01-18 CN disclosed
WO-2020207655-A1 NANOPARTICLES COMPRISING COPOLYMERIC OR HOMOPOLYMERIC COMPOUNDS WHICH COMPRISE CYANOACRYLATE SUBUNITS SINTEF TTO AS (NO) 2020-10-15 WO disclosed
US-20060030808-A1 Liquid bandage and tissue sealant ASO CORPORATION 2006-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12357581-B2 Nanoparticles comprising copolymeric or homopolymeric compounds which comprise cyanoacrylate subunits CD47, PSMA2, C3AR1 CTSK 4492/4885HCAR2 351/4885CTSL 639/4885
US-20260112694-A1 SYSTEM AND METHOD FOR IMPROVED BATTERY STRUCTURAL PROPERTIES PARG, PUF60, PHOSPHO1 CTSK 4650/4885HCAR2 3113/4885CTSL 4311/4885
US-20220160645-A1 NANOPARTICLES COMPRISING COPOLYMERIC OR HOMOPOLYMERIC COMPOUNDS WHICH COMPRISE CYANOACRYLATE SUBUNITS CD47, PSMA2, C3AR1 CTSK 4492/4885HCAR2 351/4885CTSL 639/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.